Qualities of Controlled Clinical Trials Relevant to Acupuncture and Moxibustion Treatment of Cardiovascular Disease in Literatures Published in China from 1990——2009

LI Xiang,ZHENG Ya-yuan,WANG Ming-min,LIU Ying,XIAO Jun-jie,CHEN Yi-han
DOI: https://doi.org/10.3969/j.issn.1008-0392.2011.02.023
2011-01-01
Abstract:Objective To investigate the qualities of disease published in China in recent 20 years. Methods The clinical research literatures relevant to acupuncture and moxibustion treatment of cardiovascular disease were searched in several databases including the Chinese Biologic Medicine Database disc(CMBdisc),China National Knowledge Infrastructure Database(CNKI),Chongqing VIP full-text Database(VIP),and Wanfang Database.The keywords used were:clinicalcare,clinical research,randomization,control,blind,acupuncture,hypertension,coronary heart diseaseandarrhythmiaand all references included in the analysis were between 1990 and 2009. The evaluation of clinical trial quality was in accordance withJadad Measuring Scaleandthe control groupin the research and was scored from 0 to 5.Results Three hundred and sixty articles with full-text copies online were identified.The common diseases in the above clinical research were hypertension(38.1%),coronary heart disease(32.8%),arrhythmia(20.6%).The treatments(62.4%) adopted were simple acupuncture treatment intervention.The proportion ofno randomization or quasirandomization,randomization without description in detailsandrandomization with description of appropriate methodwere 47.2%,34.7%,18.1%,respectively.The proportion of articles withappropriate control groupwas 60%.Theblind methodwas only found in 3 articles.Score distribution from the worst to the best of the clinical research by quality scale(from 0 to 5) were 0(6.9%),1(12.8%),2(31.9%),3(18.1%),4(0.3%),and 5(0%),respectively,with the mean score of 1.32.Conclusion Though some progress has been made in quantity and quality of articles related to the controlled clinical trials relevant to acupuncture and moxibustion treatment of cardiovascular disease in China during recent years,great challenges still exist in terms of the overall quality.
What problem does this paper attempt to address?